Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.
- DOI
- 10.1080/2162402x.2025.2595764
- Published
- 2025 Dec 31
- Container
- Oncoimmunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/2162402x.2025.2595764,
title = {Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.},
author = {Brand M and Adamik J and Wang H and Sember SE and Muzzio JL and Buffo MJ and Sander CA and Kirkwood JM and Ferris RL and Butterfield LH and Vujanovic L},
year = {2025},
journal = {Oncoimmunology},
doi = {10.1080/2162402x.2025.2595764},
url = {https://doi.org/10.1080/2162402x.2025.2595764}
}RIS
TY - JOUR TI - Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness. AU - Brand M AU - Adamik J AU - Wang H AU - Sember SE AU - Muzzio JL AU - Buffo MJ AU - Sander CA AU - Kirkwood JM AU - Ferris RL AU - Butterfield LH AU - Vujanovic L PY - 2025 JO - Oncoimmunology DO - 10.1080/2162402x.2025.2595764 UR - https://doi.org/10.1080/2162402x.2025.2595764 ER -
APA
M, B., J, A., H, W., SE, S., JL, M., MJ, B., CA, S., JM, K., RL, F., LH, B., & L, V. (2025). Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.. Oncoimmunology. https://doi.org/10.1080/2162402x.2025.2595764
Source records
- pubmed · retrieved 2026-09-27T08:16:31.455Z